Search results
Results from the WOW.Com Content Network
Lupin's businesses encompass the entire pharmaceutical value chain, ranging from branded and generic formulations, APIs, advanced drug delivery systems to biotechnology. . The company's drugs reach 70 countries [22] with a footprint that covers advanced markets such as USA, Europe, Japan, [23] Australia as well as emerging markets including India, the Philippines and South Africa to name a
Gupta joined Lupin in 1993, [3] and became CEO in 2013. Gupta was the chairman and CEO of Lupin Pharmaceuticals Inc, from 2003 to 2013, and grew the US business from 5% to over 45% of Lupin's total turnover. [2] The US is Lupin's largest market. [citation needed] Lupin's estimated annual cost savings to the US health system is approximately $15 ...
He is the only son of Desh Bandhu Gupta, who founded Lupin in 1968. [3] His eldest sister, Vinita D. Gupta, is the CEO. [citation needed]He has a bachelor's degree in chemical engineering from the University Department of Chemical Technology, Mumbai, and an MBA from the Wharton School, University of Pennsylvania, U.S. in 2002, [3] [1] where he specialized in healthcare, strategic management ...
Nearly a week after Lupin Pharmaceuticals announced a voluntary recall of two types of blood pressure medications, the company continues to see its stock price slide (though the hit could have ...
US subsidiary of the company, no separate notability DGG 00:35, 2 February 2014 (UTC) Disagree, its not subsidiary of US. Actually US Lupin is subsidiary of Indian company . Lupin Limited is Primary/Head Company. KuwarOnline Talk 20:20, 29 March 2014 (UTC)
Founded in 1961, the company was first located in an abandoned skating rink in White Sulphur Springs, West Virginia. [12] [13] The facility was moved to Pennsauken, New Jersey in 1962, [14] to Princeton, West Virginia in 1963, and then Morgantown, West Virginia, in 1965, and in 1976 it relocated its corporate headquarters to the Pittsburgh suburb Canonsburg, Pennsylvania.
Alvogen is a private, US-based pharmaceuticals company founded in 2009. Since 2015, it has been majority-owned by CVC Capital Partners and Temasek Holdings. [2] Alvogen focuses on so-called 'difficult-to-make' generic drugs and injectables, and both produces its own products and markets the products of brand name pharmaceutical companies.
She joined Pfizer in 1974, and steadily rose through the ranks, becoming President of Pharmaceuticals in 1995. [3] Launches by Pfizer during her tenure included Lipitor and Viagra . [ 2 ] During her leadership, Pfizer’s U.S. Pharmaceuticals Group achieved record financial performance each ear, with 1999 revenues over $9.2 billion.